FFJ’s work helps maintain order in the one area of American civic life — the capital markets — where integrity and standards are increasingly marginalized.
Below are examples where FFJ helped play a role in identifying serious abuse and wrongdoing, often months or years prior to legal or regulatory action. That is a valuable economic and legal service the government ought to provide, and FFJ does it without ads and with no profit motives.
Consider: Blyth, Anthony Davian, Medbox, Bryan Caisse, Benjamin Wey, InterCloud, AmTrust/Karfunkel Foundations, OvaScience, Insys Therapeutics, Valeant Pharmaceuticals, Synchronoss Technologies, Corcept Therapeutics, Myriad Genetics, Teladoc Health, Newton Glassman, Wirecard AG.
In 2020 FFJ has released two long-form investigations (see here and here), participated in ABC News’ eight-part series on Jeffrey Epstein, and helped produce a “Frontline” documentary to be released in June.
For the balance of the year, FFJ has another three (and possibly four) accountability investigations slated for publication and will return to covering publicly-traded companies whose governance and disclosures are, to be charitable, profoundly worthy of skepticism.
The need is especially vital in 2020: FFJ’s “Libel Insurance” — better known as Error & Omissions coverage — premiums went up 275%. And a Canadian private equity magnate named Newton Glassman dragged FFJ into litigation against reporters and short-sellers in Toronto, which required FFJ pay a $50,000, one-time deductible to defend its co-writer.